Tech Company Financing Transactions

InCode BioPharmaceutics Funding Round

On 6/18/2007, InCode BioPharmaceutics announced $2 million in investment from Avalon Ventures.

Transaction Overview

Announced On
6/18/2007
Transaction Type
Venture Equity
Amount
$2,000,000
Round
Undisclosed
Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
P.O. Box 7118
Thousand Oaks, CA 91359
USA
Email Address
Overview
The company develops therapeutic compounds to treat autoimmune disorders.
Profile
InCode BioPharmaceutics LinkedIn Company Profile
Social Media
InCode BioPharmaceutics Company Twitter Account
Company News
InCode BioPharmaceutics News
Facebook
InCode BioPharmaceutics on Facebook
YouTube
InCode BioPharmaceutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Kevin Stark
  Kevin Stark LinkedIn Profile  Kevin Stark Twitter Account  Kevin Stark News  Kevin Stark on Facebook


 

 

Browse more venture capital transactions:

Prev: 6/15/2007: StackSafe venture capital transaction
Next: 6/18/2007: PetFoodDirect.com venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to document every notable VC transaction. VC investment data records reported here come from company press releases and news coverage. The data is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary